MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Biallelic Variants in ACER3 Encoding Alkaline Ceramidase 3 Cause Infantile- and Early-Childhood-Onset Neurodegeneration with Progressive Leukodystrophy

    R. Kaiyrzhanov, A. Study Group, H. Houlden, R. Maroofian (Shymkent, Kazakhstan)

  • Bias in Pharmacoepidemiological Studies of Parkinson’s Disease Prescribing Patterns: A Systematic Review

    K. Orayj (Abha, Saudi Arabia)

  • Bidirectional Relationships Between Frailty and DNAm Age Acceleration and its Mediation Effects on Physical Disability and Mortality

    C. Han, J. Chhetri, P. Chan (Beijing, China)

  • Bilateral Pallidal Deep Brain Stimulation in Secondary Dystonia in Louis-Bar-Syndrome Patients – A Report of Two Cases-

    N. Warneke, I. Claus, V. Zentsch, W. Stummer (Münster, Germany)

  • Biological Characteristics of Individuals with RBD: A Multicenter Prospective Longitudinal Cohort

    J. Feuerstein, E. Brown, L. Chahine, C. Gochanour, D. Lafontant, M. Marshall, T. Simuni, D. Weintraub (Aurora, USA)

  • Biomarker Panels for Parkinson’s Disease using Multi-Omics Approach: Recent Developments and Future Directions

    PRA. Sharma, RK. Dhamija (Delhi, India)

  • Blepharospasm as cause of facial pain and “sinus” headache: A case series

    J. Anang (Winnipeg, Canada)

  • Blinded video-based analysis of dystonia before and after unilateral High Intensity Focused Ultrasound thalamotomy in Essential and Dystonic Tremor

    J. Peters, J. Maamary, K. Kyle, I. Osborne, Y. Barnett, B. Jonker, S. Tisch (Darlinghurst, Australia)

  • Blood and CSF Biomarkers of Cognitive Impairment in Alpha Synucleinopathies

    C. Girges, N. Vijiaratnam, N. O’Reilly, J. Hay, V. Chelban, D. Athauda, H. Morris, H. Houlden, S. Gandhi, T. Foltynie (London, United Kingdom)

  • Blood levels of Cathepsin B are linked to a reduced risk of Parkinson’s disease

    X. Guo, R. Li (Xi'an, China)

  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley